Bexte et al. performed CRISPR-based knockout in primary NK cells and reported the enhancement of tumor cell lyses in NKG2A-KO cells in comparison with WT NK cells against multiple myeloma cells after 24 h of coculturing in the FACS-based cytotoxic assay [39]. The gene discussed is KLRC1; the disease is plasma cell myeloma.